<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Vascular <z:hpo ids='HP_0000726'>dementia</z:hpo> (VaD) accounts for about 20% of <z:hpo ids='HP_0000001'>all</z:hpo> <z:hpo ids='HP_0000726'>dementias</z:hpo>, and vascular risk is a key factor in more than 40% of people with <z:e sem="disease" ids="C0002395" disease_type="Disease or Syndrome" abbrv="SDAT">Alzheimer's disease</z:e> (AD) </plain></SENT>
<SENT sid="1" pm="."><plain>Little is known about inflammatory processes in the brains of these individuals </plain></SENT>
<SENT sid="2" pm="."><plain>We have examined <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> (interleukin (IL)-1beta, IL-1alpha, IL-6 and <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumour</z:e> <z:mp ids='MP_0001651'>necrosis</z:mp> factor alpha) and chemokines (macrophage inflammatory protein 1, monocyte chemo-attractant protein (<z:chebi fb="17" ids="50099">MCP</z:chebi>)-1 and granulocyte macrophage colony-stimulating factor) in brain homogenates from grey and white matter of the frontal cortex (Brodmann area 9) from patients with VaD (n = 11), those with concurrent VaD and AD (mixed <z:hpo ids='HP_0000726'>dementia</z:hpo>; n = 8) and from age-matched controls (n = 13) using ELISA assays </plain></SENT>
<SENT sid="3" pm="."><plain>We found a dramatic reduction of <z:chebi fb="17" ids="50099">MCP</z:chebi>-1 levels in the grey matter in VaD and mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> in comparison to controls (55 and 66%, respectively) </plain></SENT>
<SENT sid="4" pm="."><plain>IL-6 decreases were also observed in the grey matter of VaD and mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> (72 and 71%, respectively), with a more modest decrease (30%) in the white matter of patients with VaD or mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> </plain></SENT>
<SENT sid="5" pm="."><plain>In the first study to examine the status of <z:mp ids='MP_0002501'>inflammatory mediators</z:mp> in a brain region severely affected by white-matter lesions, our findings highlight - in contrast to previous reports in AD - that patients at the later stage of VaD or mixed <z:hpo ids='HP_0000726'>dementia</z:hpo> have a significantly attenuated neuro-<z:mp ids='MP_0001845'>inflammatory response</z:mp> </plain></SENT>
</text></document>